UBS lowered the firm’s price target on Lennox (LII) to $570 from $625 and keeps a Neutral rating on the shares. Shares fell 9% on Tuesday following “mixed” Q1 results, with concerns around near-term demand and execution challenges overshadowing the company’s meaningful pricing actions to offset tariffs and preserve profitability, the analyst tells investors in a research note. UBS is eager to see how much share Lenox can recapture in Emergency Replacement when a “normal” environment returns, and the level margin expansion off new capacity ramp.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LII:
